Teva Infringed License, Must Return Proneuron's IP Rights, Israeli Court Rules

摘要

Proneuron Biotechnologies won a longstanding intellectual property suit against Teva Pharmaceuticals on April 27, when the Tel Aviv District Court ruled that Teva had infringed the terms of a license it received from Proneuron, and must return Proneuron's technology and intellectual property rights immediately.